Literature DB >> 32208673

Liposomes for Antibiotic Encapsulation and Delivery.

Azucena Gonzalez Gomez1, Zeinab Hosseinidoust1,2.   

Abstract

When antibiotics are administered, orally or intravenously, they pass through different organs and layers of tissue on their way to the site of infection; this can cause dilution and/or intoxication. To overcome these problems, drug delivery vehicles have been used to encapsulate and deliver antibiotics, improving their therapeutic index while minimizing their adverse effects. Liposomes are self-assembled lipid vesicles made from at least one bilayer of phospholipids with an inner aqueous compartment. Liposomes are attractive vehicles to deliver antibiotics because they can encapsulate both hydrophobic and hydrophilic antibiotics, they have low toxicity, and they can change the biodistribution of the drug. Furthermore, liposomes have been approved by regulatory agencies. However, most developmental and mechanistic research in the field has been focused on encapsulation and delivery of anticancer drugs, a class of molecules that differ significantly in chemistry from antibiotics. In this critical Review, we discuss the state of knowledge regarding the design of liposomes for encapsulation and delivery of antibiotics and offer insight into the challenges and promises of using liposomes for antibiotic delivery.

Entities:  

Keywords:  antibacterial; lipid bilayers; nanodrug delivery; nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 32208673     DOI: 10.1021/acsinfecdis.9b00357

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  13 in total

Review 1.  Recent Advances in Antimicrobial Nano-Drug Delivery Systems.

Authors:  Tong-Xin Zong; Ariane Pandolfo Silveira; José Athayde Vasconcelos Morais; Marina Carvalho Sampaio; Luis Alexandre Muehlmann; Juan Zhang; Cheng-Shi Jiang; Shan-Kui Liu
Journal:  Nanomaterials (Basel)       Date:  2022-05-29       Impact factor: 5.719

Review 2.  Nanoantibiotics: Functions and Properties at the Nanoscale to Combat Antibiotic Resistance.

Authors:  M Mustafa Mamun; Adeola Julian Sorinolu; Mariya Munir; Eric P Vejerano
Journal:  Front Chem       Date:  2021-05-13       Impact factor: 5.221

3.  Exploring New Horizons in Liquid Compartmentalization via Microfluidics.

Authors:  Shauni Keller; Serena P Teora; Moussa Boujemaa; Daniela A Wilson
Journal:  Biomacromolecules       Date:  2021-04-09       Impact factor: 6.988

Review 4.  No Solid Colloidal Carriers: Aspects Thermodynamic the Immobilization Chitinase and Laminarinase in Liposome.

Authors:  Dania Alonso-Estrada; Nayra Ochoa-Viñals; Sandra Pacios-Michelena; Rodolfo Ramos-González; Arianna Núñez-Caraballo; Lourdes Georgina Michelena Álvarez; José Luis Martínez-Hernández; Alberto Antonio Neira-Vielma; Anna Ilyina
Journal:  Front Bioeng Biotechnol       Date:  2022-02-07

5.  Preparation, Characterization, and Evaluation of Liposomes Containing Oridonin from Rabdosia rubescens.

Authors:  Yinyue Wang; Mai Wang; Feier Lin; Xinyan Zhang; Yongming Zhao; Chunyan Guo; Jin Wang
Journal:  Molecules       Date:  2022-01-27       Impact factor: 4.411

6.  Sulfonium-based liposome-encapsulated antibiotics deliver a synergistic antibacterial activity.

Authors:  Anjali Patel; Subhasis Dey; Kamal Shokeen; Tomasz M Karpiński; Senthilkumar Sivaprakasam; Sachin Kumar; Debasis Manna
Journal:  RSC Med Chem       Date:  2021-05-24

7.  Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii.

Authors:  Reem E Alarfaj; Manal M Alkhulaifi; Ahmed J Al-Fahad; Shokran Aljihani; Alaa Eldeen B Yassin; Majed F Alghoribi; Majed A Halwani
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

Review 8.  β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects.

Authors:  Karl A Glen; Iain L Lamont
Journal:  Pathogens       Date:  2021-12-18

9.  Bacteriomimetic Liposomes Improve Antibiotic Activity of a Novel Energy-Coupling Factor Transporter Inhibitor.

Authors:  Menka Drost; Eleonora Diamanti; Kathrin Fuhrmann; Adriely Goes; Atanaz Shams; Jörg Haupenthal; Marcus Koch; Anna K H Hirsch; Gregor Fuhrmann
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

10.  The Analysis of Chitosan-Coated Nanovesicles Containing Erythromycin-Characterization and Biocompatibility in Mice.

Authors:  Loredana Nicoleta Hilițanu; Liliana Mititelu-Tarțău; Grațiela Eliza Popa; Beatrice Rozalina Buca; Liliana Lăcrămioara Pavel; Ana-Maria Pelin; Andreea-Daniela Meca; Maria Bogdan; Daniela Angelica Pricop
Journal:  Antibiotics (Basel)       Date:  2021-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.